Compare GSK Consumer with Venky's - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs VENKYS - Comparison Results

GSK CONSUMER     Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER VENKYS GSK CONSUMER/
VENKYS
 
P/E (TTM) x 39.1 -52.2 - View Chart
P/BV x 11.0 2.5 444.3% View Chart
Dividend Yield % 1.0 0.5 189.7%  

Financials

 GSK CONSUMER   VENKYS
EQUITY SHARE DATA
    GSK CONSUMER
Mar-19
VENKYS
Mar-19
GSK CONSUMER/
VENKYS
5-Yr Chart
Click to enlarge
High Rs7,8194,725 165.5%   
Low Rs5,8321,787 326.4%   
Sales per share (Unadj.) Rs1,136.92,159.8 52.6%  
Earnings per share (Unadj.) Rs233.7123.6 189.1%  
Cash flow per share (Unadj.) Rs248.1144.4 171.8%  
Dividends per share (Unadj.) Rs105.008.00 1,312.5%  
Dividend yield (eoy) %1.50.2 626.1%  
Book value per share (Unadj.) Rs973.5625.6 155.6%  
Shares outstanding (eoy) m42.0614.09 298.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.01.5 398.2%   
Avg P/E ratio x29.226.3 110.9%  
P/CF ratio (eoy) x27.522.5 122.1%  
Price / Book Value ratio x7.05.2 134.7%  
Dividend payout %44.96.5 694.2%   
Avg Mkt Cap Rs m287,08345,874 625.8%   
No. of employees `0003.85.5 69.7%   
Total wages/salary Rs m6,4461,945 331.4%   
Avg. sales/employee Rs Th12,440.25,520.9 225.3%   
Avg. wages/employee Rs Th1,677.0352.8 475.3%   
Avg. net profit/employee Rs Th2,556.7315.9 809.3%   
INCOME DATA
Net Sales Rs m47,82030,431 157.1%  
Other income Rs m4,326290 1,491.2%   
Total revenues Rs m52,14630,721 169.7%   
Gross profit Rs m11,4103,084 370.0%  
Depreciation Rs m606294 206.3%   
Interest Rs m8316 2.5%   
Profit before tax Rs m15,1232,765 546.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,2951,024 517.2%   
Profit after tax Rs m9,8281,741 564.4%  
Gross profit margin %23.910.1 235.4%  
Effective tax rate %35.037.0 94.6%   
Net profit margin %20.65.7 359.2%  
BALANCE SHEET DATA
Current assets Rs m52,6748,904 591.6%   
Current liabilities Rs m18,1405,877 308.7%   
Net working cap to sales %72.29.9 726.1%  
Current ratio x2.91.5 191.7%  
Inventory Days Days3625 141.8%  
Debtors Days Days2937 80.3%  
Net fixed assets Rs m4,7985,675 84.6%   
Share capital Rs m421141 298.5%   
"Free" reserves Rs m40,5278,674 467.2%   
Net worth Rs m40,9478,815 464.5%   
Long term debt Rs m0399 0.0%   
Total assets Rs m60,68115,573 389.6%  
Interest coverage x1,939.89.8 19,866.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.82.0 40.3%   
Return on assets %16.213.2 122.7%  
Return on equity %24.019.8 121.5%  
Return on capital %37.033.4 110.5%  
Exports to sales %00.7 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA200 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,171200 1,583.9%   
Fx outflow Rs m1,770725 244.1%   
Net fx Rs m1,401-525 -266.9%   
CASH FLOW
From Operations Rs m6,7111,589 422.3%  
From Investments Rs m-3,351-383 875.5%  
From Financial Activity Rs m-3,768-1,204 312.9%  
Net Cashflow Rs m-4082 -19,419.0%  

Share Holding

Indian Promoters % 0.0 56.1 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 8.8 9.1%  
FIIs % 12.0 3.2 381.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 31.9 46.4%  
Shareholders   26,457 20,089 131.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   ITC  TATA CONSUMER PRODUCTS  ADVANTA.  DABUR  NESTLE  

Compare GSK CONSUMER With:   TIGER BRANDS (S. Africa)  COCA COLA (US)  NESTLE (Switz.)  AVI LTD. (S. Africa)  



Today's Market

Sensex Trades Over 300 Points Lower; Dow Futures Down by 101 Points(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading up by 357 points, up 0.7% at 49,267 levels.

Related Views on News

VENKYS (I) LIMITED Announces Quarterly Results (1QFY21); Net Profit Down 24.0% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, VENKYS (I) LIMITED has posted a net profit of Rs 470 m (down 24.0% YoY). Sales on the other hand came in at Rs 5 bn (down 40.2% YoY). Read on for a complete analysis of VENKYS (I) LIMITED's quarterly results.

VENKYS (I) LIMITED Announces Quarterly Results (3QFY20); Net Profit Down 108.7% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, VENKYS (I) LIMITED has posted a net profit of Rs 59 m (down 108.7% YoY). Sales on the other hand came in at Rs 9 bn (up 8.4% YoY). Read on for a complete analysis of VENKYS (I) LIMITED's quarterly results.

Burger King IPO: Should You Subscribe to This QSR Chain Business? (IPO)

Dec 2, 2020

Does the company with one of the fastest-growing QSR chains in India have sound prospects?

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Apr 15, 2020 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 8-QTR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS